ONCS Hits New Low, AAC Trims Revenue Outlook, NVRO Down 45% YTD

The following are some of the pharma/biotech stocks that posted the biggest percentage decline today.

from RTT - Biotech https://ift.tt/2JKIL28
via IFTTT